Well-Intentioned, But Can The Improved AAC Work For UK Medtechs?

The newly enhanced Accelerated Access Collaborative (AAC) promises a more concerted effort to ensure health-care innovations reach end users. On paper, it looks good, but the medtech industry in the UK has seen several worthy efforts along similar lines ultimately amount to little. Health Enterprise East’s Dr. Anne Blackwood is reserving judgment.

Innovative idea solution concept and new thinking business symbol as a light bulb breaking through a maze or labyrinth as an icon for innovation and invention. - Illustration

The improvements to NHS England’s Accelerated Access Collaborative (AAC), announced last week, are designed to put the most promising devices, diagnostic tools, digital services and medicines through clinical development and regulatory approval processes faster.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

Medtech Seeks Inclusion In EU’s Groundbreaking Life Sciences Strategy

 

As the EU Life Sciences Strategy aims to drive innovation, the medtech sector is pushing for a pivotal role in a mission intended to embrace green and digital transitions, address regulatory obstacles and reduce dependency on external sources.

‘AI Isn’t Flying Off The Shelves In The NHS,’ Says Healthtech Startup CEO

 

Vendor exhaustion, insufficient clinical-grade evidence, and outdated risk management are some of the reasons the NHS is struggling to adopt AI. Haris Shuaib, CEO of Newton's Tree, shared his insights with the audience at the “Next Frontier of Medical AI” event held at DAC Beachcroft's London office on 23 April.